Solid Biosciences Inc. SLDB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s total current liabilities?
- Solid Biosciences Inc. (SLDB) reported total current liabilities of $30.28M in Q1 2026.
- How has Solid Biosciences Inc.'s total current liabilities changed year-over-year?
- Solid Biosciences Inc.'s total current liabilities increased by 5.2% year-over-year, from $28.78M to $30.28M.
- What is the long-term trend for Solid Biosciences Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s total current liabilities has grown at a 6.5% compound annual growth rate (CAGR), from $24.48M to $33.47M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.